Stop mixing GMV + GMC! 🚫 Treat them as distinct yet synergistic markers ➝ sharper insights into #Autism’s pathology + development!🧠💡 #PrecisionNeuroscience @elsevierconnect.bsky.social @sciencedirect.bsky.social #Neurobiology #ASD
doi.org/10.1016/j.ne...

Cofounder of Neuralink rival Precision Neuroscience reveals what people often get wrong about brain implants Neurosurgeon Dr. Ben Rapoport, cofounder of Precision Neuroscience, debunks what he believes is a misconception about brain-computer interfaces.

#Neuralink isn’t the only game in town.
#PrecisionNeuroscience just got #FDA clearance for human trials of a wireless #brainimplant - no craniotomy needed. A paper-thin array sits on the brain’s surface, already tested in 40+ patients. Digital control for paralysis is closer than ever. #Neuroskyence

7/9 'So much better and more informative' than destroying whole brain regions (past century approach). 'That brain region may have a hundred different cell types'—precise activation/inactivation reveals more about how circuits work. Tested in mice, rats, macaques.
#PrecisionNeuroscience

Precision Neuroscience Secures FDA Clearance: A Conservative Win for Responsible Innovation / Technology | Conservative Compass By David N. Harding, Staff Writer

www.conservativecompass.com/technology/2...

#precisionneuroscience #MedicalInnovation #ConservativeValues #healthcare #paralysistreatment #braincomputerinterface #ethicaltechnology #patientsafety #ResponsibleInnovation #conservativecompass #highlights

FDA clears wireless, minimally invasive brain implant by Neuralink rival A brain-computer interface (BCI) thin enough to slip under the skull has become the first of its kind to win extended FDA approval. Precision Neuroscience has received a green light from the US Food a...

A brain-computer interface thin enough to slip under the skull has become the first of its kind to win extended FDA approval. #FDA #PrecisionNeuroscience #BCI #HealthTech #Neuralink community.designtaxi.com/topic/10928-...

More Funding Raises: #LiquidAI $250M Series A; #PrecisionNeuroscience $102M Series C; #AMP $91M Series D; #Basis $34M Series A; #Decart $32M Series A; #CimulateAI $28M Series A; #SlipRobotics $28M Series B; #Pleno $25M Series B

Our latest ALS disease study mechanistically stratified heterogenous population of ALS patients, and identified novel genetic drivers of the disease, which represent potential targets linked to specific patient subgroups with supporting stratification biomarkers.

#PrecisionNeuroscience

Proud of our team’s groundbreaking work to develop better diagnostics, find more personalized treatments and create a cure for #ALS #MND.

#PrecisionNeuroscience

New findings from our ALS disease studies presented by Principal Disease Biologist, Andy Malinowski, at the Motor Neurone Disease (MND) Association's 35th International Symposium on ALS/MND.

➡️ View the poster: precisionlife.com/publication-...

#PrecisionNeuroscience

#ALS #MND #alsmndsymp

#PrecisionNeuroscience breakthroughs in the fight against ALS/MND...

Our team has unveiled groundbreaking research and the discovery of actively protective biology, novel causal targets, drug repurposing candidates, and mechanistic patient stratification biomarkers in ALS.

To find new ways of diagnosing and treating complex diseases we first must understand the mechanisms underpinning their key pathological changes – this is the basis of #PrecisionNeuroscience

🧬➡️ precisionlife.com/precision-ne...